ENTITY
Shire PLC

Shire PLC (SHP LN)

38
Analysis
Health CareIreland
SHIRE PLC is a global biotechnology group focused on serving people with rare diseases and other specialized conditions. The Company develops products across core therapeutic areas including hematology, immunology, neuroscience, ophthalmics, lysosomal storage disorders, gastrointestinal, internal medicine endocrine and hereditary angioedema, and in oncology.
more
Refresh
05 Feb 2020 06:52

🇯🇵 JAPAN • Results & Revisions Daily Roundup - 4th February ▲2371 4502 4739 ▼7741 4452 2317

4TH FEBRUARY ROUNDUP - As expected the 121 Results and 41 Forecast/Revision announcements yesterday took our Results Score 16bps lower to a new...

Logo
305 Views
Share
19 Mar 2019 03:30

China Blood Products: Deals Highlight Values

Grifols SA (GRF SM) and Shanghai RAAS Blood Products Co Ltd (002252.SZ) recently announced an asset exchange that effectively combines the...

Share
16 Dec 2018 07:46

Last Week in Event SPACE: ANTA, Japan Display, Pioneer, Naspers, Huatai, Red Hat

 Last Week in Event SPACE ... The reward/risk is pretty decent on the Anta Sports Products (2020 HK) /Amer Sports Oyj (AMEAS FH) trade. A rumoured...

Logo
509 Views
Share
bearishS&P 500 INDEX
14 Dec 2018 04:10

S&P 500 Revisiting 2,600 Support

The S&P 500 was not able to break through the 2,817 and 100-day moving average resistance levels last week, and has now fallen abruptly back to...

Logo
517 Views
Share
09 Dec 2018 22:56

Takeda and Shire Shareholders Unanimously Agree to $64b Deal

Our take… Reiterating our positive view, we think the deal could help Takeda on several fronts, including: Sizeable footprint in the strategically...

x